Enhanced Mucoadhesion of Thiolated β-Cyclodextrin by S-Protection with 2-Mercaptoethanesulfonic Acid
ACS Omega · 06.02.2024 · 9 (5) · 5819-5828
DOI: 10.1021/acsomega.3c08836 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 26.01.2024. Verfasst von Gergely Kali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80-82, A-6020 …. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aimed at designing an S-protected thiolated β-cyclodextrin (β-CD) exhibiting enhanced mucoadhesive properties. The native β-CD was thiolated with phosphorus pentasulfide resulting in a thiolated β-CD (β-CD-SH) and subsequently S-protected with 2-mercaptoethanesulfonate (MESNA) to form β-CD-SS-MESNA. The structure of the novel excipient was confirmed by 1H NMR and Fourier-transform infrared spectroscopy. The sulfhydryl content of β-CD-SH, determined by Ellman's test, was 2281.00 ± 147 μmol/g, and it was decreased to 45.93 ± 19.40 μmol/g by S-protection. Due to thiolation and S-protection, the viscosity of the mixture of mucus with β-CD-SH and β-CD-SS-MESNA increased 1.8 and 4.1-fold, compared to native β-CD, respectively. The unprotected β-CD-SH diffused to a lesser extent into the mucus than native β-CD, while S-protected β-CD-SS-MESNA showed the highest mucodiffusion among the applied CDs. A 1.5- and 3.0-fold higher cellular uptake of β-CD-SH and β-CD-SS-MESNA, compared to the native one, was established on Caco-2 cell line by flow cytometry, respectively, causing slightly decreased cell viability. On account of the enhanced mucoadhesion, this higher cellular uptake does not affect the application potential of β-CD-SS-MESNA as an oral drug delivery system since the carrier remains in the mucus and does not reach the underlying epithelial layer. According to these results, the S-protection of β-CD-SH with MESNA promotes improved mucodiffusion, strong mucoadhesion, and prolonged mucosal residence time.
Autor:innen und Institutionen
- Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80-82, A-6020 Innsbruck, Austria.
- Department of Pharmacy, University of Bari Aldo Moro, Piazza Cesare Battisti, I-70121 Bari, Italy.
ORCID-Profile: Gergely Kali, Nunzio Denora, Andreas Bernkop-Schnürch
Zitieren
APA
Kali, G., Taha, A. M. M. M., Campanella, E., Truszkowska, M., Haddadzadegan, S., Denora, N., & Bernkop-Schnürch, A. (2024). Enhanced Mucoadhesion of Thiolated β-Cyclodextrin by S-Protection with 2-Mercaptoethanesulfonic Acid. ACS Omega, 9(5), 5819-5828. https://doi.org/10.1021/acsomega.3c08836
Vancouver
Kali G, Taha AMMM, Campanella E, Truszkowska M, Haddadzadegan S, Denora N, et al. Enhanced Mucoadhesion of Thiolated β-Cyclodextrin by S-Protection with 2-Mercaptoethanesulfonic Acid. ACS Omega. 2024;9(5):5819-5828. doi:10.1021/acsomega.3c08836
BibTeX
@article{Kali2024,
author = {Kali, Gergely and Taha, Ali Magdi Mahmoud Mahmoud and Campanella, Emiliano and Truszkowska, Martyna and Haddadzadegan, Soheil and Denora, Nunzio and Bernkop-Schnürch, Andreas},
title = {Enhanced Mucoadhesion of Thiolated β-Cyclodextrin by S-Protection with 2-Mercaptoethanesulfonic Acid},
journal = {ACS Omega},
year = {2024},
volume = {9},
number = {5},
pages = {5819--5828},
doi = {10.1021/acsomega.3c08836}
}
EUVIMED